MTOR and cervical carcinoma: Xie et al [10] have recently reported that a dual PI3K/mTOR inhibitor NVP-BEZ235 treatment in combination with cisplatin or carboplatin induced a synergistic antitumor response in cervical carcinoma cells in vitro.